A cross-sectional randomized comparative study of topical minoxidil solution with and without finasteride in male pattern androgenetic alopecia in South Indian patients


  • C. R. V. Narasimhalu Department of Skin & STD, Saveetha Medical College, Saveetha University, Kancheepuram, Tamil Nadu




Androgenetic alopecia, Testosterone, Dihydro testosterone, Male pattern baldness, Loss of libido, Topical finasteride


Background: Finasteride is one of the common drugs used in androgenetic alopecia. Literature speaks about sexual side effects in about 2% of the patients. To overcome this, we used topical finasteride. The objective of the study was to know the efficacy of topical minoxidil solution with and without finasteride.

Methods: We randomized about 300 subjects, aged 18-45 years, who came for outpatient consultation for male pattern androgenetic alopecia into two groups. One group (group A) treated with 0.1% topical finasteride with 5% minoxidil solution and another group (group B) treated with 5% minoxidil solution after informed consent from both of them.

Results: Analysis of the extent of bald area, hair count and number of terminal hair showed no significant difference in both the groups.

Conclusions: No significant difference in the therapeutic response of topical minoxidil solution whether its plain or added with topical finasteride. So, adding topical finasteride in the minoxidil solution found to be of no value. It only adds up the cost and also creates the unnecessary fear of sexual side effects in the mind of the patients. 

Author Biography

C. R. V. Narasimhalu, Department of Skin & STD, Saveetha Medical College, Saveetha University, Kancheepuram, Tamil Nadu

Professor, Dept of Skin & STD


Roberts JL, Fielder V, Imperato-McGinley J, et al. Clinical dose ranging studies with Finasteride, a type 2 5 alpha reductase. J Am Acad Dermatol. 1999;40:930–7.

Arndt KA, Hsu JTS. Manual of dermatologic therapeutics. 7th ed. Lippincott Williams & Wilkins; 2006: 339–340.

Tosti A, Piraccini BM, Soli M. Evaluvation of sexual function in subjects taking finasteride for the treatment of androgenic alopecia. J Eur Acad Dermatol Venereol. 2001;15:418–21.

Leyden J, Dunlap F, Miller B, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol. 1999;40:930–7.

Brenner S, Matz H. Improvement in androgenic alopecia in 53–76 years old men using oral Finasteride. Int J Dermatol. 1999;38:928–30.

Price VH, Menefee E, Sanchez M, Ruane P, Kaufman KD. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with Finasteride, 1 mg, and daily. J Am Acad Dermatol 2002;46:517-23.

Valia RG, Valia AR. IADVL textbook of dermatology. Volume 1. 3rd ed. 894.

Hamilton JB. Male hormone stimulation is prerequisite and an incitement in common baldness. Am J Anat. 1942;71:451–60.

Hajheydari Z, Akbari J, Saeedi M, Shookoohi L. Comparing the therapeutic effects of Finasteride gel and tablet in treatment of the androgenetic alopecia. Indian J Dermatol Venerol Leprol. 2009;75:47-51.

Kligman AM. The comparative histopathology of male pattern baldness and senescent baldness. In: De Villez RL, editor. Clinics in dermatology. Philadelphia: Lippincot; 1998: 108–113.

Hoffmann R, Van Neste D. Recent findings with computerized methods for scalp hair growth measurements. J Invest Dermatol Symp Proc. 2005;10:285–8.

Cafardi JA. Springer international ed. The manual of Dermatology. 2015: 21.

Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Lefell DJ. Fitzpatrick’s Dermatology in general medicine. 7 th ed. 2008: 768.

Kaufman KD, Olsean EA, Whiting D, et al. Finasteride in the treatment of man with androgenetic alopecia. J Am Acad Dermatol. 1998;39:578–9.

Narasimhalu CRV. Randomized questionnaire based case-control research study on evaluation of the sexual function in Indian patients taking oral Finasteride for androgenetic alopecia. Dermatol Therapy. 2015;4:231-4.






Original Research Articles